NK CELL LYMPHOMA/LEUKEMIA

Clinical trials for NK CELL LYMPHOMA/LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new NK CELL LYMPHOMA/LEUKEMIA trials appear

Sign up with your email to follow new studies for NK CELL LYMPHOMA/LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug combo before transplant aims to beat rare lymphoma

Disease control Not yet recruiting

This study tests a combination of three chemotherapy drugs (thiotepa, cyclophosphamide, and busulfan) given before a stem cell transplant for people with NK/T-cell lymphoma. The goal is to see if this approach helps keep the cancer from coming back. About 37 adults aged 18-70 who…

Matched conditions: NK CELL LYMPHOMA/LEUKEMIA

Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

NK CELL LYMPHOMA/LEUKEMIA

Get alerted when new NK CELL LYMPHOMA/LEUKEMIA trials appear

New drug combo before transplant aims to beat rare lymphoma